Indian pharmaceutical majors have warned that a prolonged West Asia conflict could raise drug costs for patients due to higher freight and raw material expenses, Moneycontrol reported. The added costs are now impacting company balance sheets. For now, firms are absorbing most of the increase to ensure uninterrupted medicine supply, but caution that this may not continue if disruptions persist.